Proto Labs Inc: Form 10-Q for the period ended Mar 31, 2021
Filed with the SEC on May 10, 2021 and accepted by EDGAR at May 10, 2021, 17:21 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2021-01-01 to 2021-03-31 | $116.1m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Cost of revenue | 3 months2021-01-01 to 2021-03-31 | $60.8m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2021-01-01 to 2021-03-31 | $55.3m | us-gaap:GrossProfit |
| Research and development | 3 months2021-01-01 to 2021-03-31 | $12.2m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2021-01-01 to 2021-03-31 | $4.3m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2021-01-01 to 2021-03-31 | $236.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2021-01-01 to 2021-03-31 | $3.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2021-01-01 to 2021-03-31 | $0.13 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2021-01-01 to 2021-03-31 | $0.14 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2021-01-01 to 2021-03-31 | 27,698,195 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2021-01-01 to 2021-03-31 | $6.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2021-01-01 to 2021-03-31 | $6.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 3 months2021-01-01 to 2021-03-31 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2021-03-31 | $43.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2021-03-31 | $158.5m | us-gaap:AssetsCurrent |
| Total assets | At period end2021-03-31 | $934.4m | us-gaap:Assets |
| Current liabilities | At period end2021-03-31 | $59.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2021-03-31 | $121.0m | us-gaap:Liabilities |
| Shareholders' equity | At period end2021-03-31 | $813.4m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001437749-21-011560. Last ingested by Listed: Nov 4, 2026, 18:20 ET. Listed shows no prices and gives no investment advice.